Fibrobiologics Inc (FBLG)

Nov 15, 2024

HC Wainwright Expects Stronger Earnings for FibroBiologics - MarketBeat

Nov 15, 2024

Nov 14, 2024

Fibrobiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction in Cell-Based Therapeutics - Marketscreener.com

Nov 14, 2024

Nov 14, 2024

FibroBiologics files patent for reducing cell therapy risks - Investing.com

Nov 14, 2024

Nov 14, 2024

FibroBiologics seeks patent for clot-prevention method - Investing.com

Nov 14, 2024

Nov 14, 2024

FibroBiologics Files Patent Application Covering Reduction - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with ... - The Bakersfield Californian

Nov 14, 2024

Nov 14, 2024

FibroBiologics Files Patent for Breakthrough Cell Therapy Blood Clotting Prevention | FBLG Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Is FibroBiologics (NASDAQ:FBLG) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

FibroBiologics' (FBLG) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 13, 2024

Nov 12, 2024

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

FibroBiologics Reports Wider Q3 Loss, Advances Clinical Pipeline Amid R&D Push | FBLG Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

FibroBiologics Inc. (FBLG) Quarterly 10-Q Report - Quartzy

Nov 12, 2024

Nov 09, 2024

FBLGFibroBiologics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 09, 2024

Nov 03, 2024

HC Wainwright Begins Coverage on FibroBiologics (NASDAQ:FBLG) - Defense World

Nov 03, 2024

Nov 01, 2024

HC Wainwright Forecasts FibroBiologics Q3 Earnings - MarketBeat

Nov 01, 2024

Oct 31, 2024

H.C. Wainwright sets stock target on FibroBiologics shares, cites portfolio By Investing.com - Investing.com Australia

Oct 31, 2024

Oct 30, 2024

FibroBiologics (NASDAQ:FBLG) Coverage Initiated by Analysts at HC Wainwright - MarketBeat

Oct 30, 2024

Oct 30, 2024

FibroBiologics names interim CFO as Mark Andersen steps down By Investing.com - Investing.com Australia

Oct 30, 2024

Oct 29, 2024

FibroBiologics CFO Andersen Resigns - MarketWatch

Oct 29, 2024

Oct 29, 2024

FibroBiologics names interim CFO as Mark Andersen steps down - Investing.com India

Oct 29, 2024

Oct 29, 2024

FibroBiologics reports breakthrough in artificial thymus research - Investing.com

Oct 29, 2024

Oct 29, 2024

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology - GlobeNewswire

Oct 29, 2024

Oct 29, 2024

FibroBiologics, Inc. Announces Updates for Novel Artificial Thymus Organoid Technology - Marketscreener.com

Oct 29, 2024

Oct 28, 2024

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024 - GlobeNewswire

Oct 28, 2024

Oct 21, 2024

FibroBiologics and Charles River link for chronic disease therapies manufacture - Yahoo News

Oct 21, 2024

Oct 18, 2024

FibroBiologics, Charles River Partner To Manufacture Cell-Based Therapies - Contract Pharma

Oct 18, 2024

Oct 18, 2024

FibroBiologics partners with Charles River for DFU trial production - Investing.com

Oct 18, 2024

Oct 18, 2024

FibroBiologics and Charles River Announce Collaboration to - GlobeNewswire

Oct 18, 2024

Oct 18, 2024

FibroBiologics partners with Charles River for DFU trial production By Investing.com - Investing.com UK

Oct 18, 2024

Oct 18, 2024

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based ... - Post Register

Oct 18, 2024

Oct 18, 2024

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases - ForexTV.com

Oct 18, 2024

Oct 16, 2024

FibroBiologics Shares Rise After European Patent for Fibroblast Cancer Treatment - MarketWatch

Oct 16, 2024

Oct 16, 2024

FibroBiologics secures patent for cancer treatment method - Investing.com

Oct 16, 2024

Oct 16, 2024

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office - GlobeNewswire

Oct 16, 2024

Oct 14, 2024

Short Interest in FibroBiologics, Inc. (NASDAQ:FBLG) Increases By 21.6% - MarketBeat

Oct 14, 2024

Oct 11, 2024

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit - The Manila Times

Oct 11, 2024

Oct 03, 2024

FBLG Stock Earnings: FibroBiologics, Inc. – Common Stock Reported Results for Q1 2024 - MSN

Oct 03, 2024

Sep 30, 2024

FibroBiologics, Inc. (NASDAQ:FBLG) Short Interest Update - MarketBeat

Sep 30, 2024

Sep 30, 2024

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa - GlobeNewswire

Sep 30, 2024

Sep 25, 2024

Take off with FibroBiologics Inc (FBLG): Get ready for trading - SETE News

Sep 25, 2024

Sep 24, 2024

FibroBiologics (NASDAQ:FBLG) Now Covered by Analysts at Maxim Group - MarketBeat

Sep 24, 2024

Sep 24, 2024

Maxim Group Initiates Coverage of FibroBiologics (FBLG) with Buy Recommendation - MSN

Sep 24, 2024

Sep 23, 2024

Market Insights: FibroBiologics Inc (FBLG)’s Notable Gain of 4.43, Closing at 3.30 - The Dwinnex

Sep 23, 2024

Sep 19, 2024

Falcon’s Beyond Global, Inc. (NASDAQ:FBYDW) Short Interest Update - Defense World

Sep 19, 2024

Sep 19, 2024

FibroBiologics engages Southern Star Research as CRO in Australia - TipRanks

Sep 19, 2024

Sep 19, 2024

FibroBiologics Engages Southern Star Research as CRO in Australia - GlobeNewswire

Sep 19, 2024

Sep 19, 2024

Five9, Inc. (NASDAQ:FIVN) Shares Acquired by Edgestream Partners L.P. - Defense World

Sep 19, 2024

Sep 19, 2024

FibroGen Inc (FGEN) can make a big difference with a little luck - SETE News

Sep 19, 2024

Sep 19, 2024

FibroGen Inc (FGEN) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle

Sep 19, 2024

Sep 19, 2024

Brown Brothers Harriman & Co. Has $104,000 Holdings in Fidus Investment Co. (NASDAQ:FDUS) - Defense World

Sep 19, 2024